UFIS-SWE-IG
0.1.0 - ci-build

UFIS-SWE-IG, published by UNICOM. This guide is not an authorized publication; it is the continuous build for version 0.1.0 built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/joofio/ufis-swe-ig/ and changes regularly. See the Directory of published versions

Example RegulatedAuthorization: Bamyl500mgtablett-SE-PLC-RA

Generated Narrative: RegulatedAuthorization Bamyl500mgtablett-SE-PLC-RA

identifier: http://ema.europa.eu/fhir/marketingAuthorizationNumber/14792

subject: MedicinalProductDefinition: identifier = http://ema.europa.eu/fhir/mpId#SE-100001270-00014792,http://ema.europa.eu/fhir/eurdId#39; domain = Human use; status = Current; combinedPharmaceuticalDoseForm = Tablet; indication = Smärttillstånd såsom huvudvärk, tandvärk, led-och muskelsmärtor och dysmenorré. Feber vid förkylningssjukdomar. Reumatoid artrit. Till barn med feber som ej svarat på gängse behandling endast efter kontakt med läkare.; legalStatusOfSupply = Medicinal product subject to medical prescription exempt for some pack sizes; classification = acetylsalicylic acid

type: Marketing Authorisation

region: Kingdom of Sweden

status: Valid

statusDate: 2000-12-29

holder: Organization Meda AB

Cases

-TypeDate[x]
*First Authorisation2000-12-29